Form SC 13G/A Gemini Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP Feb 4, 2022 09:27AM
Gemini Therapeutics (GMTX) Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration Feb 8, 2021 07:07AM
Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration Feb 8, 2021 07:00AM